Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Emodin Inhibits the Growth and Invasion and Induces Apoptosis and Autophagy in Hepatocellular Carcinoma via PI3K/AKT/mTOR and Wnt/β-catenin Pathway

View through CrossRef
Abstract Background: Previous studies reported that emodin extracted from Rheum palmatum L. exerts antiproliferation and antimetastatic effects in a variety of human cancer types. However, the role of emodin in hepatocellular carcinoma (HCC) remain unknown.Methods: EdU and colony formation assays were performed to evaluate the effects of emodin on proliferation. The mobility capacities of HCC treated with emodin were evaluated using wound healing assay. Transwell invasion and migration assays were performed to evaluate anti-migratory and anti-invasive effects of emodin on HCC. Annexin V-FITC/PI was performed to analyze the apoptosis. PI stain was performed to analyze cell cycle. RNA sequencing technology was used to identify the differentially expressed genes (DEGs) induced by emodin in HCC. The impact of emodin on autophagic flux in HepG2 cells was examined by mCherry-GFP-LC3 analysis. Western blot was used to assess the protein expressions of epithelial-mesenchymal transition (EMT), autophagy, PI3K/AKT/mTOR and Wnt/β-catenin signaling pathway.Results: We found that emodin inhibited the growth of HepG2 cells in a dose- and time-dependent manner. In addition, emodin inhibited cell proliferation, induced S and G2/M phases arrest, and promoted apoptosis in HepG2 cells. The migration and invasion of HepG2 cells were also suppressed by emodin. Enrichment analysis revealed that DEGs involved in cell adhesion, cancer metastasis and cell cycle arrest. Moreover, western blot and bioinformatics analysis indicated that emodin induced autophagy and inhibited the EMT in part through suppression of the PI3K/AKT/mTOR and Wnt/β-catenin pathways. Conclusion: Our study indicated that emodin inhibited cell metastasis in HCC via the crosstalk between autophagy and EMT.
Title: Emodin Inhibits the Growth and Invasion and Induces Apoptosis and Autophagy in Hepatocellular Carcinoma via PI3K/AKT/mTOR and Wnt/β-catenin Pathway
Description:
Abstract Background: Previous studies reported that emodin extracted from Rheum palmatum L.
exerts antiproliferation and antimetastatic effects in a variety of human cancer types.
However, the role of emodin in hepatocellular carcinoma (HCC) remain unknown.
Methods: EdU and colony formation assays were performed to evaluate the effects of emodin on proliferation.
The mobility capacities of HCC treated with emodin were evaluated using wound healing assay.
Transwell invasion and migration assays were performed to evaluate anti-migratory and anti-invasive effects of emodin on HCC.
Annexin V-FITC/PI was performed to analyze the apoptosis.
PI stain was performed to analyze cell cycle.
RNA sequencing technology was used to identify the differentially expressed genes (DEGs) induced by emodin in HCC.
The impact of emodin on autophagic flux in HepG2 cells was examined by mCherry-GFP-LC3 analysis.
Western blot was used to assess the protein expressions of epithelial-mesenchymal transition (EMT), autophagy, PI3K/AKT/mTOR and Wnt/β-catenin signaling pathway.
Results: We found that emodin inhibited the growth of HepG2 cells in a dose- and time-dependent manner.
In addition, emodin inhibited cell proliferation, induced S and G2/M phases arrest, and promoted apoptosis in HepG2 cells.
The migration and invasion of HepG2 cells were also suppressed by emodin.
Enrichment analysis revealed that DEGs involved in cell adhesion, cancer metastasis and cell cycle arrest.
Moreover, western blot and bioinformatics analysis indicated that emodin induced autophagy and inhibited the EMT in part through suppression of the PI3K/AKT/mTOR and Wnt/β-catenin pathways.
Conclusion: Our study indicated that emodin inhibited cell metastasis in HCC via the crosstalk between autophagy and EMT.

Related Results

Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Abstract 630: The role of AKT pathway in β-catenin mutated hepatocellular carcinoma
Abstract 630: The role of AKT pathway in β-catenin mutated hepatocellular carcinoma
Abstract The Wnt/β-catenin and PI3K/AKT pathways are pivotal contributors to the development of the malignant phenotype in cancer. The activated Wnt/β-catenin pathwa...
Bortezomib Induces Activation of b-Catenin/TCF Signaling Pathway in Multiple Myeloma
Bortezomib Induces Activation of b-Catenin/TCF Signaling Pathway in Multiple Myeloma
Abstract Abstract 1851 Background: The proteasome inhibitor Bortezomib (Bz) shows significant activity in Multipl...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract Introduction Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Abstract 4300: The EEF1A2-PI3K-AKT-mTOR axis supports the protumorigenic function of MDM4 in human hepatocellular carcinoma.
Abstract 4300: The EEF1A2-PI3K-AKT-mTOR axis supports the protumorigenic function of MDM4 in human hepatocellular carcinoma.
Abstract Background & Aims: The Mouse Double Minute homolog 4 (MDM4) is one of the main negative p53 regulators in mammalian cells and mutational inactivation of...

Back to Top